Imugene Limited - Australian Company Profile

What does Imugene Limited do?

Imugene Limited is a Public Company that generates the majority of its income from the Scientific Research Services industry.

In 2024 the company generated total revenue of $9,486,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Imugene Limited is Mr Leslie Chong whose official title is Chief Executive Officer & Managing Director. The Chairman of Imugene Limited is Mr Paul Hopper whose official title is Executive Chairman.

Imugene Limited is engaged in the development of a range of immunotherapy based treatments for various cancers: HER-VAXX is a proprietary cancer vaccine that aims to treat breast and gastric cancer. PD1-VAXX (formerly KEY-Vaxx) is a cancer vaccine that is aimed at treating a range of cancer indications. CF33 and CF33 CD 19 is aimed at creating a safer, more potent anti cancer virus. azer-cel is cell therapy for lymphom and leukemia. VAXINIA & CHECKvacc is for treating tumors and breat cancer.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Imugene Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Imugene Limited by position type and title.

Enterprise Financials

Get a full view of Imugene Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Imugene Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Imugene Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Imugene Limited operates in.

Competitor Benchmarking

Compare Imugene Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Imugene Limited.

Subsidiaries

View a list of Imugene Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Imugene Limited, including founding information, past announcements, mergers and major projects.